36 results
8-K
EX-10.1
MIST
Milestone Pharmaceuticals Inc
31 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9:29am
8-K
EX-10.2
MIST
Milestone Pharmaceuticals Inc
31 Mar 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9:29am
8-K
EX-10.1
putshujs479 bl8hxkk
27 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.1
n4skq39t11j6
16 Feb 22
Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer
7:37am
8-K
EX-10.1
0os 421ehsut
29 Jul 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
jpl1zjn829z1
23 Jul 20
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
7:05am
8-K
EX-10.1
gzhjw4d26v
9 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.3
6mf ygddrirowi
9 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
v0ut3 cnoqg6v
9 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
9n7k1bjgg s5zzgr
10 Sep 19
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
8:45am